We are live on ! Find out more
ESPR

Esperion Therapeutics
ESPR

Delisted

ESPR was delisted on the 10th of July, 2026.

50 hedge funds and large institutions have $136M invested in Esperion Therapeutics in 2014 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 4

54% more capital invested

Capital invested by funds: $88M → $136M (+$47.9M)

16% more funds holding

Funds holding: 4350 (+7)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 15

Holders
50
Holders Change
+7
Holders Change %
+16.28%
% of All Funds
1.45%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
11
Increased
15
Reduced
15
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
PC
51
Polar Capital
United Kingdom
-$5.16M -325,639 Closed
SIM
52
SSI Investment Management
California
-$283K -17,858 Closed
PAAMCP
53
Pacific Alternative Asset Management Company (PAAMCO)
California
-$197K -12,444 Closed
VFA
54
Virtus Fund Advisers
Connecticut
-$6K -396 Closed